Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Russian leader says aims of its ‘special military operation’ will be met ‘unconditionally’ Russian affairs reporter Meanwhile, Russia’s Vladimir Putin on Wednesday lashed out at European leaders, ...
Below is a timeline of the actions the Trump administration or Congressional Republicans have taken that impact housing since President Trump took office on Jan. 20, 2025, along with additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback